Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Nightingale H1'26: Research projects accelerate H2

Research 06.03.2026, 10.44 by Antti Siltanen
Nightingale Health

Herantis H2'25: Secure financing and initiate new study

Research 06.03.2026, 10.39 by Antti Siltanen
Herantis Pharma

Faron H2'25: High stakes in financing success

Research 05.03.2026, 09.33 by Antti Siltanen
Faron Pharmaceuticals

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Aiforia H2'25 preview: Will customer wins turn into growth?

Analyst Comment 04.03.2026, 08.01 by Antti Siltanen
Aiforia Technologies

Faron H2'25 preview: Funding the research program is the next endeavor

Analyst Comment 03.03.2026, 08.15 by Antti Siltanen
Faron Pharmaceuticals

Faron and City of Hope plan new study

Analyst Comment 03.03.2026, 08.18 by Antti Siltanen
Faron Pharmaceuticals

Nightingale H1'26 preview: Revenue still relies on research projects

Analyst Comment 03.03.2026, 08.11 by Antti Siltanen
Nightingale Health

Herantis H2'25 preview: Blood-brain barrier passed and financial barriers lowered

Analyst Comment 02.03.2026, 08.19 by Antti Siltanen
Herantis Pharma

Nexstim H2'25: Overvaluation corrected

Research 27.02.2026, 08.51 by Antti Siltanen
Nexstim

Nexstim Q4'25 preview: Earnings turnaround is materializing

Analyst Comment 24.02.2026, 08.25 by Antti Siltanen
Nexstim
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.